Morrison Foerster is an international law firm with lawyers practicing throughout the United States, Asia, and Europe. Click to discover more.

mofo_share_image.jpg

Morrison Foerster

common-default.jpeg

Terms / Notices

Cookies

Privacy Policy

Reporting Hotline

Attorney Advertising

Alumni

  Linkedin

MoFo LinkedIN

  Facebook

MoFo Facebook

YouTube

MoFo Youtube

Morrison Foerster - Footer

Asia Technology Entrepreneurship Conference 2023 – Semi-Finalist Selections

You have not solved the recaptcha challenge yet or session expired, try again.

Email Disclaimer

Disclaimer

Unsolicited e-mails and information sent to Morrison Foerster will not be considered confidential, may be disclosed to others pursuant to our <a href="https://www.mofo.com/about/privacy-policy.html">Privacy Policy</a>, may not receive a response, and do not create an attorney-client relationship with Morrison Foerster. If you are not already a client of Morrison Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

Feedback

mofo-logo-2022.svg

People

Capabilities

Resources

About

Community

Offices

Careers

Stay Connected

As part of Morrison Foerster’s long-term commitment to the startup and venture capital ecosystem and technology development in Asia, we are proud to sponsor once again the Asia Technology Entrepreneurship 

<h3>Sorry, we weren’t able to find the terms you entered.</h3>Please try a different term or keyword.

People

Capabilities

Resources

Not Found Cards

As part of Morrison Foerster’s long-term commitment to the startup and venture capital ecosystem and technology development in Asia, we are proud to sponsor once again the Asia Technology Entrepreneurship Conference (ATEC) Startup Competition 2023, the largest university alumni club-led technology conference and startup competition in Asia.On 10 June, together with other profound private equity and venture capital investors, MoFo partners Thomas Chou, Maureen Ho, and Rongjing Zhao will be joining as judges at the semi-finalist selection evaluating committed startups and talented entrepreneurs including in B2C/B2B, Deep Tech, and Healthcare sectors.25 semi-finalists will advance to the next rounds of pitching and audience voting between July and September. The final competition will be held on 4 November.The competition is founded by the Hong Kong and South China University and business school alumni clubs of Harvard, Columbia, MIT, and Stanford.﻿<a href="https://www.atecstartup.org/competition.html" target="_blank">Read more</a> about the competition.<hr>

Asia Technology Entrepreneurship Conference 2023 – Semi-Finalist Selections

Sign Up

Thomas Chou is the Managing Partner of Morrison Foerster’s Los Angeles office, where he advises on cross-border mergers and acquisitions, joint ventures, and private equity and venture capital financings, with a focus on the U.S. and Asia. With more than 25 years of experience, Thomas brings deep cross-border expertise, having practiced in MoFo’s Palo Alto, Shanghai, Hong Kong, and now Los Angeles offices. During his time in Asia, he served as head and co-head of the firm’s Asia Private Equity practice for 15 years.Thomas’ clients include industry-leading emerging growth companies and a broad range of investors who fund them (traditional private equity and venture capital funds, prominent Asian family offices, the corporate/strategic investment arms of large corporates, insurance companies, and sovereign wealth funds). His broad industry coverage includes media, entertainment and gaming; CPG/food and beverage; hard tech; Fintech; biopharma, MedTech, health and wellness.Clients and outside ranking organizations routinely cite Thomas’ accomplishments:<ul><li>Thomas is “a strong advocate for his client, offering strategic and actionable advice, evaluating and clearly prioritizing the key issues in complex situations and proactively anticipating concerns from counterparties in negotiations."</li><li>“Thomas Chou is excellent in understanding the industry and leads the team in working on the same. He is very responsive and works 24 hours responding to the clients.”</li><li>“Thomas has significant experience handling complex cross–border transactions across the Asia–Pacific region. His counsel is frequently sought by global technology corporations to advise on their investments in the region. He also commands considerable respect from private equity clients.”</li><li>His clients pinpoint his “decades of venture capital experience both in the United States and in Asia,” with one noting: “He is patient, attentive to details and someone who has clearly conquered many battlefields.”</li><li>Thomas is particularly praised for his communications skills, with clients saying, “Any issues we had he would always provide a solution. He is not only interpreting regulations, but he is also commercially savvy.”</li></ul>Thomas is on the Board of the Morrison Foerster Foundation and a member of the board of directors of the Starlight Children’s Foundation.

周至恒（Thomas Chou）律师在公司业务领域非常活跃，重点处理跨境并购（中国境内外）、合资、私募股权和风险资本融资业务。他的客户包括新兴成长型公司，传统以及非传统投资者（私募股权和风险投资基金，家族办公室，公司/公司的战略投资部门，金融机构以及主权财富基金）。他的执业领域主要是技术、媒体和电信、医疗和生命科学以及消费和零售业。客户和外部评级机构都经常称赞周律师的成就：<ul><li>“周律师在处理亚太地区复杂跨境交易方面经验丰富，全球科技公司常因在该地区的投资而寻求其意见，他也广受私募股权客户推崇。”</li><li>“（周律师）资历深厚，精于各种风险投资及私募股权事宜，包括前期与后期的投资及并购，他在科技领域的经验尤其丰富。”</li><li>客户赞赏他“在美国及亚洲均有数十年风险投资经验”，并称其“非常耐心，注重细节，实战经验丰富”。</li><li>周律师的沟通技巧尤其为人所称道，他的客户指出：“不管我们出现任何问题，周律师都能提出解决方案。他不仅能准确把握法律条文，同时极具商业头脑。”</li></ul>周律师是美富亚洲私募股权业务的联席主管，也是新兴公司 + 风险投资业务组和并购业务组的活跃成员。他在上述业务领域均持续受到独立的法律行业排行榜和律师评级机构的高度认可。周律师还是星光儿童基金会的董事会成员。

Thomas Chou

Managing Partner, Los Angeles

Rongjing has over 17 years’ experience advising private equity firms, institutional investors and major corporations on complex cross-border transactions, including control deals and leveraged buyouts, mergers and acquisitions, growth capital investments, spin-offs, and distressed M&A transactions. She primarily represents private equity funds in their investments and acquisitions in Asia and strategic clients in their outbound investments and acquisitions outside China. She also has extensive experience advising clients on take privates of U.S.-listed companies and other U.S. public and private company M&A transactions. Rongjing has advised a wide range of global and regional financial sponsors, including Ascendant Capital, Advantage Partners, Bain, Blackstone, Carlyle, Centurium Capital, Canada Pension Plan Investment Board (CPPIB), CITIC Capital/Trustar, China International Capital Corporation, Clearlake, Hillhouse, KKR, PAG, L Catterton, Silver Lake and Warburg Pincus. She has also advised major technology companies and multiple listed companies (including those listed on the NYSE, Nasdaq, Hong Kong Stock Exchange and Shenzhen/Shanghai Stock Exchange) on their most strategic acquisitions and investments.Rongjing was named “Lawyer of the Year (PE Foreign Firm)” by The Legal 500 China Awards in 2024 and a “Top 15 Female Lawyer” by Asian Legal Business China in 2024. She is “Highly Recommended for China Private Equity and China Corporate and M&A” by The Legal 500 Asia Pacific in 2024–2025. Clients praised Rongjing as “a lawyer with strategic insights and pragmatic commercial sense and an impressive ability to manage complex cross-border transactions.”Prior to joining MoFo, Rongjing was a partner in a leading international law firm’s Hong Kong and Shanghai offices for several years. She is a native Mandarin speaker and fluent in English. <h4>Representative Matters</h4><h5>Private Equity Investments and Controlling/Buyout Transactions </h5><ul><li>Ascendent Capital Partners in its US$1.66 billion privatization of Hollysys Automation Technologies Ltd. (NASDAQ: HOLI), a leading international automation control system solutions provider. </li><li>The Carlyle Group <ul><li>in its leveraged buyout of HCP Packaging, a global designer and manufacturer of packaging containers for the beauty industry, from Baring Private Equity Asia. This transaction was included in “Deals of the Year 2022” by China Business Law Journal;</li><li>in its US$1.05 billion leveraged buyout of VXI Global Solutions, a U.S.-based multinational service provider with major operations in the United States, Southeast Asia, Europe, and China; </li><li>and Anchor Equity Partners in their respective investments in Airoha Technology Corp., a global leading communications solutions fabless integrated circuit design house based in Taiwan, majority-owned and controlled by MediaTek Inc. (TWSE: 2454);  </li><li>with CITIC Limited and CITIC Capital Holdings in the US$2.08 billion acquisition of the McDonald’s operations in China and Hong Kong and negotiation of a 20-year master franchise agreement―the largest McDonald’s franchise in the world; </li><li>in its US$150 million investment in OneSmart Education Group (NASDAQ: ONE); </li><li>in its pre-IPO investment in Neiwai Inc., a Shanghai-based lingerie retail group; and</li><li>in its RMB530 million investment in Beijing Ubox Technology & Trade Co., Ltd, a leading vending machine operator in China. </li></ul></li><li>Centurium Capital in its US$150 million pre-IPO investment in NTX Group, a global textile technology company.</li><li>China International Capital Corporation in its pre-IPO convertible bond investment of an auto finance company and the subsequent restructuring and litigation. </li><li>Clearlake Capital Group and its portfolio company Alkegen, one of the largest specialty materials platforms in the world, on its US$470 million partial tender offer in Luyang Energy-Saving Materials Co. Ltd., a Shenzhen Stock Exchange-listed company (SZSE: 002088). </li><li>Coatue Management in its investment in Niutron Technologies, AI Rudder Technologies, Rox (Cay) Holdings Ltd; and the US$700 million pre-IPO investment in Dingdong Maicai (NYSE: DDL).  </li><li>KKR in its US$645 million sale of MMI Holdings to a Chinese consortium and the subsequent restructuring to regain control. </li></ul><h5>Cross-Border/Public M&A Transactions  </h5><ul><li>OcuMension Therapeutics (HKSE: 01477), a Hong Kong Stock Exchange listed ophthalmic pharmaceutical platform in China </li><ul><li>in its acquisition of substantial assets valued at HK$1.28 billion (approximately US$165 million) from Alcon Inc., a global leader in eye care. The transaction involves asset purchase, global license, transition services and manufacture and supply arrangement and constitutes a very substantial transaction of OcuMension.</li><li>in its PIPE investment in Alimera Sciences, Inc., a U.S. pharmaceutical company (NASDAQ: ALIM). </li></ul><li>Sea Limited (NYSE: SE) in its acquisition of Phoenix Labs, an acclaimed independent games development company based in Vancouver.</li><li>Vimicro International Corp (NASDAQ: VIMC) in its going-private transaction.</li><li>Webull Corporation in three rounds of equity financings and pre-IPO financing, which raised over US$460 million in total. </li></ul>

赵律师执业超过十七年，她为私募股权基金、机构投资者和大型企业提供法律建议，对处理复杂的跨境交易（包括控股交易和杠杆收购、并购、成长型资本投资、分拆和困境企业并购交易）拥有丰富经验。赵律师主要代表私募股权基金处理其在中国和亚洲其他地区的投资和收购交易，以及战略客户在中国境外的投资、出海和并购交易，她还领导了众多美国上市公司的私有化交易和其他美国上市及私有公司涉及的复杂交易事务。赵律师曾为众多全球及地区性金融投资机构提供法律服务，其中包括上达资本、Advantage Partners、贝恩资本、黑石、凯雷投资、辰德资本、加拿大养老基金投资委员会、中信资本/信宸资本、中国国际金融股份有限公司、Clearlake 清湖资本、高瓴资本、KKR、太盟投资集团（PAG）、L Catterton、银湖资本以及华平投资等。她还曾协助多家领先的科技公司及多家上市公司（包括在纽约证券交易所、纳斯达克、香港联交所及深圳/上海证券交易所上市的公司）完成其最具战略意义的并购和投资交易。赵律师在2024年荣获《法律500强》中国大奖“年度最佳律师（私募股权-外资律所）”称号，并被《亚洲法律杂志》（Asian Legal Business China）评选为“2024年中国15佳女律师”。她还在《亚太法律500强指南（2024-2025）》中被评为“中国私募股权及中国公司并购领域的高度推荐律师”。客户评价她“具备战略洞察力和务实的商业思维，并在管理复杂跨境交易方面展现出卓越的能力。”在加入美富之前，赵律师曾在一家领先的国际律师事务所的香港和上海办事处担任合伙人数年。赵律师的母语为普通话，精通英语。<h4>具有代表性的交易</h4><h5>私募股权投资和控股/收购交易 </h5><ul><li>代表上达资本处理和利时自动化技术有限公司（纳斯达克股票代码：HOLI）16.6 亿美元的私有化事宜。</li><li>代表凯雷投资集团 <ul><li>处理其向霸菱亚洲投资基金对HCP Packaging公司进行的杠杆收购。HCP Packaging是一家美容行业包装容器的全球设计与制造商，该交易被《商法》杂志评为“2022年度交易”；</li><li>处理其以10.5亿美元对VXI Global Solutions进行的杠杆收购，该公司是一家美国跨国服务提供商，在美国、东南亚、欧洲和中国有大量业务；</li><li>处理其和Anchor Equity Partners分别投资达发科技股份有限公司的事宜。达发科技是一家全球领先的通信解决方案无晶圆厂集成电路设计公司，其总部位于台湾，由联发科技股份有限公司（台交所代码：2454）持有多数股权并控制；</li><li>处理其与中信股份有限公司和中信资本控股组成的联合投资团以20.8亿美元收购麦当劳中国内地和香港业务的事宜，以及关于有效期20年的特许经营主协议的谈判（是麦当劳在全球规模最大的特许经营权）；</li><li>处理其针对精锐教育集团（纳斯达克代码：ONE）的1.5亿美元投资；</li><li>处理其对中国内衣零售集团内外集团的上市前投资；以及</li><li>处理其针对中国领先的售货机经营商北京友宝科斯科贸有限公司的人民币5.3亿元投资。</li></ul></li><li>代表大钲资本处理其针对全球纺织技术公司NTX Group的1.5亿美元上市前投资。</li><li>代表中国国际金融股份有限公司处理其对一家汽车金融公司的上市前可转换债券投资以及此后的重组和诉讼事宜。</li><li>代表清湖资本集团及其投资组合公司奇耐亚太处理其以4.7亿美元对深圳证券交易所上市公司山东鲁阳节能材料股份有限公司（深交所代码：002088）的部分要约收购。奇耐亚太是全球最大的特种材料平台之一。</li><li>代表Coatue Management处理其对Niutron Technologies、AI Rudder Technologies、Rox (Cay) Holdings Ltd的投资，及其对叮咚买菜（纽交所代码：DDL）的7亿美元上市前投资。</li><li>代表KKR公司处理其以6.45亿美元将MMI Holdings公司出售给一个中国财团，以及其后为重获控股权进行的重组事宜。</li></ul><h5>跨国并购/上市公司并购交易 </h5><ul><li>代表香港上市的中国眼科制药平台欧康维视生物医药(港交所代码：01477) <ul><li>处理其收购全球眼科护理领域的领导者爱尔康公司价值 12.8 亿港元（约 1.65 亿美元）重大资产的事宜。交易涉及资产收购，以及全球许可、过渡期服务、生产和供应安排等，是欧康维视的一项非常重大交易。</li><li>处理其对美国制药公司Alimera Sciences, Inc.（纳斯达克: ALIM）进行PIPE投资的事宜。</li></ul></li><li>代表欧康维视生物（港交所代码：1477）处理其对美国制药公司Alimera Sciences, Inc.（纳斯达克: ALIM）进行PIPE投资的事宜。</li><li>代表冬海集团（纽交所代码：SE）处理其收购总部位于温哥华的知名独立游戏开发公司Phoenix Labs。</li><li>代表中星微电子有限公司（纳斯达克代码：VIMC）处理其私有化交易。</li><li>代表微步集团 (Webull Corporation)处理其三轮股权融资和上市前融资事宜，共筹集超过4.6亿美元。</li></ul>

Asia Technology Entrepreneurship Conference 2023 – Semi-Finalist Selections

10 Jun 2023 9:00 AM - 6:00 PM HKT